Iolanda Riba-Llena

Dr. Iolanda Riba-Llena


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2013 in BMC Neurology
Verified
Journal Article
Open access
PDF file
IRIolanda Riba-Llena
Iolanda Riba-Llena
CJCarmen Ioana Jarca
Carmen Ioana Jarca
XMXavier Mundet
Xavier Mundet
JTJose L Tovar
Jose L Tovar
FOFrancesc Orfila
Francesc Orfila
MMMaria Pilar Delgado Martínez
Maria Pilar Delgado Martínez
Background: Silent brain infarcts are detected by neuroimaging in up to 20% of asymptomatic patients based on population studies. They are five times more frequent than stroke in general population, and increase significantly both with advancing age and hypertension. Moreover, they are independently associated with the risk of future stroke and cognitive decline. Despite these numbers and the clinical consequences of silent brain infarcts, their prevalence in Mediterranean populations is not well known and their role as predictors of future cerebrovascular and cardiovascular events in hypertensive remains to be determined. ISSYS (Investigating Silent Strokes in Hypertensives: a magnetic resonance imaging study) is an observational cross-sectional and longitudinal study aimed to: 1- determine the prevalence of silent cerebrovascular infarcts in a large cohort of 1000 hypertensives and to study their associated factors and 2-to study their relationship with the risk of future stroke and cognitive decline. Methods/Design: Cohort study in a randomly selected sample of 1000 participants, hypertensive aged 50 to 70 years old, with no history of previous stroke or dementia. On baseline all participants will undergo a brain MRI to determine the presence of brain infarcts and other cerebrovascular lesions (brain microbleeds, white matter changes and enlarged perivascular spaces) and will be also tested to determine other than brain organ damage (heart-left ventricular hypertrophy, kidney-urine albumin to creatinine ratio, vessels-pulse wave velocity, ankle brachial index), in order to establish the contribution of other subclinical conditions to the risk of further vascular events. Several sub-studies assessing the role of 24 hour ambulatory BP monitoring and plasma or genetic biomarkers will be performed. Follow-up will last for at least 3 years, to assess the rate of further stroke/transient ischemic attack, other cardiovascular events and cognitive decline, and their predictors. Discussion: Improving the knowledge on the frequency and determinants of these lesions in our setting might help in the future to optimize treatments or establish new preventive strategies to minimize clinical and socioeconomic consequences of stroke and cognitive decline.

1 February 2020 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
JBJoan Balado
Joan Balado
IRIolanda Riba-Llena
Iolanda Riba-Llena
JPJesús Pizarro
Jesús Pizarro
APAntoni Palasí
Antoni Palasí
APAnna Penalba
Anna Penalba
MMMaria Pilar Delgado Martínez
Maria Pilar Delgado Martínez

13 January 2020 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
IRIolanda Riba-Llena
Iolanda Riba-Llena
JÁJosé Álvarez-Sabin
José Álvarez-Sabin
OROdile Romero
Odile Romero
ESEstevo Santamarina
Estevo Santamarina
GSGabriel Sampol
Gabriel Sampol
PDPilar Delgado
Pilar Delgado
Study Objectives:The objective of this study was to determine which respiratory and architectural sleep parameters are related to cognitive function and cognitive status (mild cognitive impairment ...

7 November 2023 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
EPElena Palà
Elena Palà
PGPaula García-Rodríguez
Paula García-Rodríguez
ABAlejandro Bustamante
Alejandro Bustamante
AMAnna Penalba Morenilla
Anna Penalba Morenilla
MLMarcel Lamana-Vallverdú
Marcel Lamana-Vallverdú
JMJoan Montaner
Joan Montaner